Adriana Tajonar Ph.D Overview
- Company
- Nested Therapeut...
- Primary Position
-
Board Observer
- Primary Industry
-
Healthcare
- Active Board Seats
-
1
- Med. Deal Size
-
- Med. Valuation
-
Adriana Tajonar Ph.D General Information
Biography
Dr. Adriana Tajonar serves as Board Observer at Nested Therapeutics. She served as a Principal at The Column Group. She was a Board Member at Carmot Therapeutics. She joined The Column Group in 2015. Previously, She was an Entrepreneurship Program Manager at QB3 (California Institute for Quantitative Biosciences), where she helped over 200 teams of scientists from top institutions in California start companies in the life sciences. Prior to QB3, she studied mechanisms of self-renewal and survival in human embryonic stem cells in the laboratory of Professor Douglas Melton, completing her PhD at Harvard University in 2012. Previously, she did research in the lab of Professor Rudolf Jaenisch as an undergraduate at the Massachusetts Institute of Technology. She served as Board Member at A2 Biotherapeutics.
Contact Information
Address
- 1030 Massachusetts Avenue
- Suite 410
- Cambridge, MA 02138
- United States
Adriana Tajonar Ph.D Board Seats (1)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Nested Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Cambridge, MA |
Adriana Tajonar Ph.D Lead Partner on Deals (2)
Adriana Tajonar Ph.D has been the lead partner on 2 deals. Their latest deal was with A2 Bio, a biotechnology company. The deal was made for on 05-Nov-2019.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
A2 Bio | 05-Nov-2019 | Early Stage VC (Series A) | Completed | Biotechnology | Agoura Hills, CA | |
Carmot Therapeutics | 17-Jan-2018 | Completed | Biotechnology | Berkeley, CA |
Adriana Tajonar Ph.D Network (59)
Board Members (30)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Timothy Kutzkey Ph.D | Carmot Therapeutics | The Column Group | Berkeley, CA | |
Michael Gallo Ph.D | A2 Bio | Self | Agoura Hills, CA | |
Nested Therapeutics | Nested Therapeutics | Cambridge, MA | ||
Carmot Therapeutics | Carmot Therapeutics | Berkeley, CA | ||
A2 Bio | Self | Agoura Hills, CA |
Portfolio Executives (21)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Michael Gallo Ph.D | A2 Bio | Co-Founder & Board Member | 05-Nov-2019 | Agoura Hills, CA |
Alexander Kamb Ph.D | A2 Bio | Co-Founder, Chief Scientific Officer & Board Member | 05-Nov-2019 | Agoura Hills, CA |
A2 Bio | Co-Founder | 05-Nov-2019 | Agoura Hills, CA | |
A2 Bio | Chief Business Officer | 05-Nov-2019 | Agoura Hills, CA | |
A2 Bio | Chief Operating Officer | 05-Nov-2019 | Agoura Hills, CA |
Fund Team Members (8)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Timothy Kutzkey Ph.D | The Column Group | Column Group II | San Francisco, CA |
Timothy Kutzkey Ph.D | The Column Group | Column Group III | San Francisco, CA |
The Column Group | San Francisco, CA | ||
The Column Group | San Francisco, CA | ||
The Column Group | San Francisco, CA |
Adriana Tajonar Ph.D Affiliated Funds (3)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Column Group II | The Column Group | Venture - General | Closed | 2014 | ||||
Column Group III | The Column Group | Venture - General | Closed | 2016 | ||||
The Column Group Fund | The Column Group | Hedge Fund | Liquidated |
Adriana Tajonar Ph.D FAQs
-
Who is Adriana Tajonar Ph.D?
Dr. Adriana Tajonar serves as Board Observer at Nested Therapeutics.
-
How much does Adriana Tajonar Ph.D typically invest?
Adriana Tajonar Ph.D's median deal size is
. -
What is Adriana Tajonar Ph.D’s main position?
Adriana Tajonar Ph.D’s primary position is Board Observer.
-
How many active board seats does Adriana Tajonar Ph.D hold?
Adriana Tajonar Ph.D holds a board seat in Nested Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »